Biocidin LSF® Broad-Spectrum Liposomal Formula
QuickSilver Scientific is very excited to be able to offer Liposomal delivery of our broad-spectrum Biocidin® combination as specialized nutritional support. Physicians’ reports of reduction in pain and other symptoms in as little as 4-6 weeks of use have been very encouraging. University research continues with Biocidin® in addressing biofilm encapsulated infections.
Lyme disease is on the rise, and in chronic Lyme disease and other neurological conditions, treatment is often more challenging, as pathogens can hide in the central nervous system or other fatty tissues, and may be part of a biofilm matrix. In Lyme, not only are the Borrelia burgdorferi spirochetes present, other co-infections such as Babesia are common.
Key Benefits of Biocidin® LSF
with Etheric Delivery™
Assists in delivery of broad-spectrum botanicals to the central nervous system, a key benefit when addressing Lyme disease or other pathogens*
Promotes intracellular absorption of ingredients*
Enhances lymphatic circulation of therapeutic compounds*
Unilamellar Vesicles have optimal particle size of 100 nanometers
Immediate bioavailability from oral cavity
Assists in removal of biofilms*
Artemisinin is an active constituent of the plant Artemisia annua, also known as sweet wormwood or Qinghaosu. Artemisinin is a sesquiterpene lactone. Artemisinin and other sesquiterpene lactones have been demonstrated to modulate immune system function and inflammation via inhibition of a variety of cytokines including nuclear factor κB (NF-κB), tumor necrosis factor (TNF)-α, interleukin- (IL-) 1β, and IL-6.*
Artemisinin may impact the microbial ecosystem of the digestive system, genitourinary tract, blood, and beyond, as it has been shown to have broad microbial-balancing actions.* It also may impact biofilms which make infections such as Candida albicans resistant to treatment.* It also may impact biofilms which make infections such as Candida albicans resistant to treatment.* *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Traditional artemisinin preparations have a short half-life, and low bioavailability. Liposomal delivery systems have been shown to lead to more stable artemisinin plasma concentrations, suggesting that they lead to an extended release and thereby prolonged systemic effect.* The liposomal format absorbs in the lymphatics, which lessens the burden on the liver and makes it a safer alternative for prolonged supplementation.*
The phospholipids delivered with artemisinin nourish the membranes of the cells, ensuring proper function for the absorption of nutrients and the excretion of cellular waste products and toxins.*
Do not take when pregnant or breastfeeding. It is advisable to monitor liver function enzymes during usage.
Store at room temperature.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Serving Size: 5mL (1 tsp)
Servings per container: 24